Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TRELSTAR
- The COSMYC Trial (COmbined Suppression of MYC)
- Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
- Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
- COMbination of Bipolar Androgen Therapy and Nivolumab
- Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
- Management of Castration-Resistant Prostate Cancer With Oligometastases
- Micro RNAs to Predict Response to Androgen Deprivation Therapy
- High-Dose Brachytherapy in Treating Patients With Prostate Cancer
- Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance
- Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
- RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)
- Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty
Clinical trials list
click for details